DAXOR director receives 2,500 stock options grant

DAXOR CORP reported that director-level insider Caleb DesRosiers received a grant of stock options for 2,500 shares of common stock at an exercise price of $10.14 per share.

Rhea-AI Filing Summary

DAXOR CORP reported that director-level insider Caleb DesRosiers received a grant of stock options for 2,500 shares of common stock at an exercise price of $10.14 per share. These options are contingent on SEC approval of an amendment to the Daxor Corporation 2020 Incentive Compensation Plan and will vest in three annual installments through June 23, 2028.

Insider Trade Summary

Grant/Award: 2,500 shares

Grant/Award 1 txn

Insider DesRosiers Caleb

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock options (right to buy)	2,500	$0.00	$0.00

Holdings After Transaction: Stock options (right to buy) — 2,500 contracts (Direct)

Footnotes (2)

1. F1. Stock options granted on June 23, 2026 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")
2. F2. The stock options will vest in three (3) installments - June 23, 2026 (833); June 23, 2027 (833); June 23, 2028 (834)

Key Figures

Stock options granted: 2,500 options Exercise price: $10.14 per share Expiration date: June 23, 2031 +4 more

7 metrics

Stock options granted 2,500 options Grant to Caleb DesRosiers on June 23, 2026

Exercise price $10.14 per share Conversion or exercise price for the options

Expiration date June 23, 2031 Option term end date

Post-transaction derivative holdings 2,500 options Total stock options held after the grant

First vesting tranche 833 options Vesting on June 23, 2026

Second vesting tranche 833 options Vesting on June 23, 2027

Third vesting tranche 834 options Vesting on June 23, 2028

Key Terms

Stock options, Incentive Compensation Plan, vest

3 terms

Stock options financial

"Stock options granted on June 23, 2026 are contingent on the approval"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

Incentive Compensation Plan financial

"to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")"

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

vest financial

"The stock options will vest in three (3) installments - June 23, 2026 (833)"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DAXOR CORP (DXR) report for Caleb DesRosiers?

DAXOR CORP reported that Caleb DesRosiers received a grant of stock options covering 2,500 shares of common stock. The options are a compensation-related award rather than an open-market purchase or sale, reflecting equity-based incentives tied to the company’s stock price.

What are the key terms of Caleb DesRosiers’ DAXOR (DXR) stock option grant?

The grant covers 2,500 stock options with an exercise price of $10.14 per share and an expiration date of June 23, 2031. These options entitle the holder to buy DAXOR common shares at that fixed price if vesting and other conditions are satisfied.

How and when do the DAXOR (DXR) options granted to Caleb DesRosiers vest?

The stock options vest in three installments: 833 options on June 23, 2026, 833 on June 23, 2027, and 834 on June 23, 2028. This schedule spreads vesting across three years, encouraging longer-term alignment with company performance.

Are the new DAXOR (DXR) stock options to Caleb DesRosiers immediately effective?

No. The stock options granted on June 23, 2026 are contingent on SEC approval to amend the Daxor Corporation 2020 Incentive Compensation Plan. The award’s effectiveness depends on that regulatory approval, as stated in the accompanying footnote.

How many DAXOR (DXR) derivative securities does Caleb DesRosiers hold after this grant?

After the transaction, Caleb DesRosiers holds 2,500 stock options according to the reported data. These options represent rights to acquire DAXOR common shares in the future, subject to vesting, plan terms, and the stated exercise price and expiration date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 05:08 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DesRosiers Caleb

(Last) (First) (Middle)

109 MECO LANE

(Street)

OAK RIDGE, TENNESSEE 37830

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAXOR CORP [ DXR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options (right to buy)	$10.14	06/23/2026(1)		A		2,500		(2)	06/23/2031	Common Stock	2,500	$0	2,500	D

Explanation of Responses:

1. Stock options granted on June 23, 2026 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")

2. The stock options will vest in three (3) installments - June 23, 2026 (833); June 23, 2027 (833); June 23, 2028 (834)

	/s/ Caleb DesRosiers	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)